These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 29634417)
1. Ocak M; Beaino W; White A; Zeng D; Cai Z; Anderson CJ Cancer Biother Radiopharm; 2018 Mar; 33(2):74-83. PubMed ID: 29634417 [TBL] [Abstract][Full Text] [Related]
2. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates. Beaino W; Anderson CJ J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059 [TBL] [Abstract][Full Text] [Related]
3. Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice. Zeng D; Guo Y; White AG; Cai Z; Modi J; Ferdani R; Anderson CJ Mol Pharm; 2014 Nov; 11(11):3980-7. PubMed ID: 24720806 [TBL] [Abstract][Full Text] [Related]
4. (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Wei L; Ye Y; Wadas TJ; Lewis JS; Welch MJ; Achilefu S; Anderson CJ Nucl Med Biol; 2009 Apr; 36(3):277-85. PubMed ID: 19324273 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. Sprague JE; Kitaura H; Zou W; Ye Y; Achilefu S; Weilbaecher KN; Teitelbaum SL; Anderson CJ J Nucl Med; 2007 Feb; 48(2):311-8. PubMed ID: 17268030 [TBL] [Abstract][Full Text] [Related]
6. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. Cai Z; Ouyang Q; Zeng D; Nguyen KN; Modi J; Wang L; White AG; Rogers BE; Xie XQ; Anderson CJ J Med Chem; 2014 Jul; 57(14):6019-29. PubMed ID: 24983404 [TBL] [Abstract][Full Text] [Related]
7. Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors. Jiang M; Ferdani R; Shokeen M; Anderson CJ Nucl Med Biol; 2013 Feb; 40(2):245-51. PubMed ID: 23265977 [TBL] [Abstract][Full Text] [Related]
8. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator. Guo Y; Ferdani R; Anderson CJ Bioconjug Chem; 2012 Jul; 23(7):1470-7. PubMed ID: 22663248 [TBL] [Abstract][Full Text] [Related]
9. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652 [TBL] [Abstract][Full Text] [Related]
10. Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases. Wadas TJ; Deng H; Sprague JE; Zheleznyak A; Weilbaecher KN; Anderson CJ J Nucl Med; 2009 Nov; 50(11):1873-80. PubMed ID: 19875645 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64. Jensen AI; Binderup T; Kumar EK P; Kjær A; Rasmussen PH; Andresen TL Biomacromolecules; 2014 May; 15(5):1625-33. PubMed ID: 24645913 [TBL] [Abstract][Full Text] [Related]
12. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis. Dumont RA; Deininger F; Haubner R; Maecke HR; Weber WA; Fani M J Nucl Med; 2011 Aug; 52(8):1276-84. PubMed ID: 21764795 [TBL] [Abstract][Full Text] [Related]
13. Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies. Persson M; Hosseini M; Madsen J; Jørgensen TJ; Jensen KJ; Kjaer A; Ploug M Theranostics; 2013; 3(9):618-32. PubMed ID: 24052804 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃. Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers. Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436 [TBL] [Abstract][Full Text] [Related]
16. Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer. Nedrow JR; Latoche JD; Day KE; Modi J; Ganguly T; Zeng D; Kurland BF; Berkman CE; Anderson CJ Mol Imaging Biol; 2016 Jun; 18(3):402-10. PubMed ID: 26552656 [TBL] [Abstract][Full Text] [Related]
17. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors. Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983 [TBL] [Abstract][Full Text] [Related]
18. Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer. Li J; Zheng H; Bates PJ; Malik T; Li XF; Trent JO; Ng CK Nucl Med Biol; 2014 Feb; 41(2):179-85. PubMed ID: 24373858 [TBL] [Abstract][Full Text] [Related]
19. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975 [TBL] [Abstract][Full Text] [Related]